EmergoPharm Spółka z ograniczoną odpowiedzialnością Sp. K.

Certificate TNP/MDR/0054/5756/2026

Rev. ver. 01Issued

Valid until: May 18, 2031

Certificate TNP/MDR/0054/5756/2026 is a valid Quality management system issued to EmergoPharm Spółka z ograniczoną odpowiedzialnością Sp. K. and registered in EUDAMED. Valid until May 18, 2031. View the full certificate record on MD Atlas.

Overview

Certificate number: TNP/MDR/0054/5756/2026
Certificate type: Quality management system
Certificate status: Issued
Applicable legislation: MDR [Regulation (EU) 2017/745 on medical devices]
Version: 1
Certificate ID: 2274TNP/MDR/0054/5756/2026ver. 01

Validity

Issued: May 19, 2026
Valid from: May 19, 2026
Valid until: May 18, 2031

Manufacturer

Manufacturer: EmergoPharm Spółka z ograniczoną odpowiedzialnością Sp. K.
Manufacturer SRN: PL-MF-000007178
Manufacturer country: Poland

Notified body

Notified body
Notified body SRN: 2274
Notified body country: Poland

Covered devices

Oritolin spray do gardłaClass IIa
5902020885038T

Characteristics

Sterile: No
Human tissues: No
Animal tissues: No
In vitro diagnostics: No
Initial registration: Yes
New device: No
Discard allowed: No
SSCP enabled: Yes
Mechanism of scrutiny: No
Intended medical purpose: No
SPP applicable

History

No status changes or preceding certificates are recorded.

Scope coverage

Class IIa2

2 scopes

Spray do gardła / Throat spray
Class IIa
DEVICE
Class IIa

Documents

LanguagesENPL